GSK exercises option for AM803, a FLAP inhibitor which recently completed phase I studies SAN DIEGO, June 2, 2008 — Amira Pharmaceuticals today announced that under the terms of a worldwide exclusive agreement entered into in Feb 2008, GlaxoSmithKline (GSK)… Read More
By SETH SCHIESEL MY Times Back in the analog era, delivering mass entertainment meant helping people connect with a character, a brand or a franchise. Few companies were more successful with that approach than Disney, with its stable of pop… Read More
By Samantha Marshall dkc NEWS Who needs big record labels? Not U2 and Jay-Z, who left their companies in the past two weeks to sign on with Live Nation. Madonna, Radiohead and Nine Inch Nails have also voted with their… Read More
San Diego Competitive With New England and Silicon Valley in National Ranking By Ned Randolph San Diego Business Journal Staff San Diego continues to stake a claim as a leading biotech center, finishing as No. 3 in venture capital investments… Read More
PR Newswire — March 31, 2008 SAN DIEGO, March 31 /PRNewswire/ — Amira Pharmaceuticals, a small molecule pharmaceutical company focused on the discovery and development of compounds to treat inflammatory disease, today announced the appointment of two additional members to… Read More
View Lazard Capital Markets Company Note (PDF) CAMBRIDGE, Mass. & SUMMIT, N.J.– Feb. 20, 2008– Acceleron Pharma, Inc. and Celgene Corporation today announced a worldwide strategic collaboration for the joint development and commercialization of ACE-011, a first-in-class, novel bone-forming compound.… Read More
Company secures deals with leading content providers including: CBS, MTV Networks, MySpace, The Weather Channel Interactive, AOL’s SHOUTcast and Scripps Networks to offer always-on personalized Internet broadcasts
By Lorie Konish Dow Jones Journal Early-stage venture capital firm Avalon Ventures has closed its eighth venture fund, reaching its fund-raising goal of just over $150 million, Avalon Managing Director Kevin Kinsella said. Read the article
Firm Adds Two Managing Directors to New Fund La Jolla, Calif. — February 20, 2008 — Avalon Ventures, an investor in early stage companies in biotechnology, wireless communications and Web media applications, today announced it has closed on its eighth… Read More
By BRAD STONE FRIENDSHIP means being able to sink each other’s battleships. That is the thinking of Mark Pincus, a well-known Silicon Valley entrepreneur who has built several Internet start-ups, including Support.com and the early social network Tribe.net. On Tuesday,… Read More
Amira Pharmaceuticals, Inc San Diego, CA – November 1, 2007– Amira Pharmaceuticals, a small molecule pharmaceutical company focused on the discovery and development of compounds to treat inflammatory disease linked to the eicosanoid pathway, today announced the appointment of Isabelle… Read More
Amira Pharmaceuticals, Inc San Diego, CA – November 1, 20072007 — Amira Pharmaceuticals, Inc. announced completion of the company’s Phase 1 clinical trial of AM103, Amira’s internally discovered oral drug candidate for the treatment of inflammatory diseases linked to the… Read More
Gary Lynch has spent decades trying to understand how the brain processes new information so that we can recall it later.
Gary Lynch’s UC Irvine research team struggles to understand how memories are made. It is crucial to treating age-related declines.
Gary Lynch and his UC Irvine lab team begin to piece together the story of human memory. Then his own brain becomes the focus.
Gary Lynch expects his brain lab’s work to bring ‘all the tribes of neuroscience to the same campfire.’ Instead, he meets resistance.
Matt Hartley With open source software becoming a household name, another open source movement that may one day see some fanfare is already taking shape. Open source hardware, which I once thought to be little more than a pipe dream… Read More
Mark Hendrickson Brooklyn-based Kaltura has earned the honor to present as the 40th company in this year’s TechCrunch40 conference, beating next generation forums provider Tangler by a handful of votes.
Entrepreneur Magazine July 2007 Great news for entrepreneurs last year: Venture capitalists invested $25.5 billion in 3,416 deals in 2006–a 10 percent increase in deal volume and a 12 percent increase in dollar values from 2005, according to the “MoneyTree… Read More
Advertiser Staff The Honolulu Advertiser InCode BioPharmaceutics Inc. in Lahaina received $3 million in venture capital from Avalon Ventures during the second quarter, according to the PriceWaterhouseCoopers Moneytree survey. The company is developing therapeutic compounds to treat autoimmune disorders. Hawaii… Read More